RVPHHealthcareMicro-Cap
REVIVA PHARMACEUTICALS HOLDINGS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are RVPH insiders buying or selling?
REVIVA PHARMACEUTICALS HOLDINGS, INC. insiders reported 10 open-market buys ($15.4M) and 14 sells ($6.7M) across 24 Form 4 filings — a net buying position of $8.8M.
Source: SEC EDGAR Form 4
Key Statistics (as of Nov 21, 2022)
Total Form 4 filings
24
SEC EDGAR
Insider filers
9
Insider buys (10)
$15.4M
Insider sells (14)
$6.7M
Insider sentiment
Net buyingNet insider flow of $8.8M in net buying.
Recent RVPH insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 21, 2022 | Purav Patel | Director | Purchase | 3.0K | $4.69 | $14.1K |
| Oct 3, 2022 | Prabhu Narayan | Chief Financial Officer | Purchase | 50.0K | $1.66 | $83.0K |
| Jun 30, 2022 | Prabhu Narayan | Chief Financial Officer | Purchase | 50.0K | $1.21 | $60.7K |
| Jun 3, 2021 | SAXENA PARAG | 10% Owner | Purchase | 1.3M | $3.75 | $5.0M |
| Dec 11, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 367.0K | $10.88 | $4.0M |
| Dec 9, 2020 | Hudson Bay Capital Management LP | 10% Owner | Sale | 50.0K | $11.51 | $575.5K |
| Dec 4, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 261 | $11.00 | $2.9K |
| Dec 2, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 11.3K | $10.95 | $124.0K |
| Nov 25, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 30.7K | $10.90 | $334.8K |
| Nov 18, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 1.3K | $10.90 | $14.5K |
| Nov 13, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 5 | $10.90 | $54.5 |
| Nov 10, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 1 | $10.90 | $10.9 |
| Nov 4, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 57.6K | $10.85 | $625.1K |
| Nov 3, 2020 | Hudson Bay Capital Management LP | 10% Owner | Sale | 40.0K | $10.99 | $439.8K |
| Oct 1, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 2 | $11.50 | $23 |
| Sep 21, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 1.0K | $10.80 | $10.8K |
| Sep 16, 2020 | GLAZER CAPITAL, LLC | 10% Owner | Sale | 1 | $10.80 | $10.8 |
| May 15, 2020 | MIZUHO SECURITIES USA LLC | 10% Owner | Sale | 51.0K | $10.62 | $541.6K |
| Sep 4, 2018 | Tenzing LLC | 10% Owner | Purchase | 33.0K | $10.00 | $330.0K |
| Sep 4, 2018 | Rahul Nayar | Chief Executive Officer | Purchase | 33.0K | $10.00 | $330.0K |
| Sep 4, 2018 | SAXENA PARAG | Chairman of the Board | Purchase | 33.0K | $10.00 | $330.0K |
| Aug 24, 2018 | Rahul Nayar | Chief Executive Officer | Purchase | 310.0K | $10.00 | $3.1M |
| Aug 24, 2018 | SAXENA PARAG | Chairman of the Board | Purchase | 310.0K | $10.00 | $3.1M |
| Aug 24, 2018 | Tenzing LLC | 10% Owner | Purchase | 310.0K | $10.00 | $3.1M |
Showing the 24 most recent of 24 Form 4 filings for REVIVA PHARMACEUTICALS HOLDINGS, INC..
Most active RVPH insiders
- GLAZER CAPITAL, LLC11 filings
- Hudson Bay Capital Management LP2 filings
- Prabhu Narayan2 filings
- Rahul Nayar2 filings
- SAXENA PARAG2 filings
Ask anything about RVPH insider activity
Use Trabud's AI agent to query REVIVA PHARMACEUTICALS HOLDINGS, INC.'s Form 4 history in plain English — "Show me RVPH CEO purchases this year" or compare it against any other ticker.
Open the AI agentRVPH insider trading FAQ
Are REVIVA PHARMACEUTICALS HOLDINGS, INC. insiders buying or selling?
Across 24 SEC Form 4 filings, REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) insiders reported 10 open-market purchases totaling $15.4M and 14 sales totaling $6.7M. That is a net buying position of $8.8M.
How many insiders trade RVPH stock?
9 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for REVIVA PHARMACEUTICALS HOLDINGS, INC.. The most recent filing was accepted on Nov 21, 2022.
Where does Trabud get RVPH insider trading data?
All RVPH insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.